EUSA Pharma, FDA approval of phase 3 clinical trial for Siltuximab in patients with COVID-19 associated Acute Respiratory Distress Syndrome ... Jul 03
The study represents the data collection and analysis of a series of patients treated under an ongoing emergency compassionate use protocol. The study will investigate ... Mar 19
-Advertisements-